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ABSTRACT
Background and Objectives: To evaluate laparoscopic
transperitoneal marsupialization of pelvic lymphocysts at
the time of laparoscopically directed assessment of
response to first-line therapy in a population of patients
treated for International Federation of Gynecologists and
Obstetricians (FIGO) stage IC-IIC epithelial ovarian cancer.
Methods: Between March 1995 and March 1998, eight
patients with FIGO stage IC-IIC serous epithelial ovarian
tumors who developed pelvic lymphocysts after primary
surgical staging underwent transperitoneal laparoscopical-
ly directed marsupialization of lymphocysts at the time of
second-look laparoscopy.
Results: The mean age of the patient population was 50
years (range 23-65 years). The mean length of time
required for marsupialization was 30 minutes (range 25-35
minutes). No patient required inpatient postoperative
care. No intraoperative complications were observed.
Computerized axial tomography (CT) scan of the
abdomen and pelvis obtained 12 weeks following surgery
failed to demonstrate re-accumulation of lymphocysts
among any patient in the study population. With a medi-
an follow-up of 20 months (range 3-39 months), no
patients have demonstrated pelvic lymphocyst recurrence.
Conclusions and Discussion: Laparoscopically directed
marsupialization of pelvic lymphocysts is technically feasi-
ble, safe and effective. Further study of this technique
appears to be warranted.
Key Words: Laparoscopy, Pelvic lymphocyst,
Marsupialization.
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INTRODUCTION
Lymphocysts are collections of serous fluid within non-
epithelial lined spaces. Surgical transection of the affer-
ent lymphatics during lymphadenectomy resulting in
inadequate closure of the lymph channels and continu-
ous drainage of lymphatic fluid lead to lymphocyst for-
mation. Lymphatic fluid clots at a much slower rate than
blood, and lymphatic channels do not undergo spasm
after transection, thus promoting accumulation of the
lymph fluid. Heparin prophylaxis, extensive nodal dis-
section, previous radiation, infection, diuretics, presence
of nodal disease, the use of drains and lack of drains
have been previously implicated as predisposing fac-
tors.
1 In 1958, Gray and coworkers reported a 16.3%
incidence of lymphocyst formation following radical
gynecological surgery.
2 A more recent retrospective
review of 308 patients who underwent retroperitoneal
lymphadenectomy and were followed postoperatively
with computerized axial tomography (CT) scans of the
abdomen and pelvis described a 20% and 32% incidence
of lymphocyst formation in patients with cervix and
ovarian cancer, respectively.
3 Most patients, however,
present with lower extremity edema, deep venous
thrombophlebitis, lower abdominal pain, ureteral
obstruction, or bladder irritability.
Although postoperative lymphocyst formation rarely
causes symptoms, patients frequently present with a pal-
pable pelvic mass. This finding alerts the clinician to
exclude recurrent disease. Recurrences have been
reported to arise within lymphocysts developing after
gynecologic cancer surgery.
4 Marsupialization of lym-
phocysts not only is diagnostic but also provides thera-
peutic relief for those patients who are clinically symp-
tomatic.
Recently, several case reports have demonstrated that
laparoscopic marsupialization of pelvic lymphocysts is
technically feasible.
5-1
0 Encouraged by these reports, we
prospectively evaluated laparoscopic transperitoneal
marsupialization of pelvic lymphocysts at the time of
laparoscopically directed assessment of response to first-
line therapy in a population of patients treated for
International Federation of Gynecologists and
Obstetricians (FIGO) stage IC-IIC epithelial ovarian can-
cer.
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Table 1.
Patient Characteristics
Patient
1
2
3
4
5
6
7
8
Stage
IC
IC
IIA
IIB
IIB
IIC
IIC
IIC
Age
(yrs.)
23
29
59
65
63
49
55
57
Lymphocyst
Size (cm)
5
7
6
6
7
9
8
9
Symptoms
Right leg
edema
Operating
Time (min)
25
28
30
33
28
35
30
32
EBLb
Minimal
Minimal
Minimal
Minimal
Minimal
Minimal
Minimal
Minimal
Follow-up
(months)
3
21
23
18
39
19
24
13
a Marsupialization time
k Estimated blood loss
MATERIALS AND METHODS
Between March 1995 and March 1998, eight patients with
FIGO stage IC-IIC serous epithelial ovarian carcinoma
underwent primary surgical staging laparotomy followed
by systemic platinum-based chemotherapy. Detection of
a pelvic mass clinically and radiographically compatible
with a pelvic lymphocyst was diagnosed in each patient
at a median of one month (range 1-2 months) (Figure 1).
Patient characteristics are outlined in Table 1. Seven
patients had no symptoms ascribable to lymphocysts, and
one patient was symptomatic. All patients were without
clinical evidence of disease following first-line therapy.
All patients demonstrated complete clinical responses to
chemotherapy and were offered laparoscopically directed
surgical assessment of response.
Preoperative evaluation included complete blood count,
chemistry profile, CA125, evaluation of coagulation
parameters, electrocardiogram, chest x-ray and comput-
erized CT evaluation of the abdomen and pelvis.
Preoperative bowel preparation consisted of a clear liq-
uid diet for one day prior to surgery and 240 cc of mag-
nesium citrate on the evening prior to surgery.
Figure 1. CT scan of the pelvis demonstrating a lymphocyst
along the right pelvic sidewall (marked by arrows) overlying the
external iliac vessels and the right ureter.
Sequential compression stockings and subcutaneous
heparin were prescribed for all patients. A nasogastric
tube was placed following the induction of general endo-
tracheal anesthesia.
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Figure 2. Laparoscopic view of the blue-domed lymphocyst
(marked with arrows).
Patients were placed in the modified lithotomy position
with both legs below the level of the iliac crest and the
legs supported in Allen stirrups. Access to the peritoneal
cavity was achieved via an infraumbilical incision
employing the technique described by Hasson.
1
1
Pneumoperitoneum was created and intra-abdominal
pressure did not exceed 15 mm of mercury. The pelvic
and abdominal contents were evaluated. Under direct
visualization, two 5 mm trocars were placed 3 cm medi-
al to each anterior iliac crest. Peritoneal cytology from
the pelvis and the paracolic gutters were procured and
submitted for permanent cytological evaluation.
Scrapings from the undersurface of the diaphragm for
cytologie analysis were also obtained. The bowel was
evaluated from the ileocecal valve to the ligament of
Treitz. Multiple pelvic peritoneal and intra-abdominal
peritoneal biopsies were obtained and submitted for
analysis.
The laparoscopic marsupialization was carried out last.
Metzenbaum scissors with monopolar cautery capability
were used to create a 4-5 cm elliptical incision in the
peritoneum overlying the lymphocyst. The cyst was
identified (Figure 2), and a laparoscopic needle was
introduced into the lymphocyst. The lymphocyst was
decompressed and the fluid that was aspirated was sub-
mitted for permanent cytological evaluation. Then a 4-5
Figure 3. Laparoscopic view after marsupialization of the lym-
phocyst.
cm elliptical incision was made on the anterior aspect of
the cyst, and the cyst wall was excised and submitted for
permanent sections. The laparoscope was then
advanced into the lymphocyst sac. Adhesions discov-
ered within the lymphocyst were lysed in order to ensure
complete drainage. The edges of the cyst wall were then
sutured to the adjacent peritoneum with four sutures of
2-0 polyglactin (Vicryl®) (Figure 3).
After hemostasis was ensured, the abdomen was decom-
pressed of intraperitoneal CO2. All trocars were removed
under direct visualization. No complications ascribable
to surgery were observed, and no patient in the study
population required hospital admission.
RESULTS
Eight patients with FIGO stage IC-IIC serous epithelial
ovarian cancer underwent laparoscopically directed
transperitoneal marsupialization of pelvic lymphocysts at
the time of surgical assessment of response to first-line
therapy. The mean age of the patient population was 50
years (range 23-65 years), the mean size of the pelvic
lymphocyst in this population was 7 cm (5-9 cm), and
the mean operating time for the marsupialization aspect
of the procedure was 30 minutes (range 25-35 minutes).
Estimated blood loss for the procedure was minimal. No
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Figure 4. CT scan demonstrating complete resolution 12 weeks
after laparoscopic marsupialization of the lymphocyst.
complications attributable to surgery were observed. No
patient required hospitalization.
All patients underwent postoperative imaging of the
abdomen and pelvis with abdominal and pelvic CT scan
examination 12 weeks postoperatively. All patients had
no residual pelvic lymphocyst on pelvic and CT scan
examination (Figure 4). With a mean follow-up of 20
months (range 3-39 months), no patient has developed
recurrence of pelvic lymphocysts. The only symptomatic
patient in this series (patient no. 1) had complete resolu-
tion of her symptoms postoperatively.
DISCUSSION
Lymphocyst formation is not an uncommon finding fol-
lowing radical pelvic surgery.
1
2 Pelvic lymphocysts are
rarely symptomatic and rarely interfere with the normal
function of abdominopelvic viscera. Troublesome, how-
ever, is the possibility, albeit rare, of an occult recurrence
within a pelvic lymphocyst.
The management of pelvic lymphocysts remains contro-
versial. Among asymptomatic patients, conventional wis-
dom holds that surgical decompression offers little
advantage over observation. However, when symptoms
ascribable to pelvic lymphocysts are documentable or
when the question of recurrence needs to be addressed,
the optimal approach to the management of lymphocysts
remains controversial.
Recently, Parra and coworkers compared current treat-
ment modalities for the management of lymphocysts
among 313 patients.
5 These researchers, in an extensive
review of the literature, describe an unacceptably high
recurrence rate when simple aspiration of a lymphocyst
is attempted as definitive therapy and point out that
repeat attempts at aspiration may be accompanied by
serous infectious morbidity.
13,1
4
The employment of CT versus sonographically directed
percutaneous aspiration appears to be a more successful
technique. However, the risk of trauma to adjacent struc-
tures and morbidity associated with the maintenance of
catheters employed for continuous drainage continue to
present substantial risks for complications.
5,1
3
Internal marsupialization at the time of laparotomy
remains the gold standard for the treatment of lympho-
cysts. Less than 20% of such patients suffer re-accumu-
lation of lymphatic fluid.
5 This technique, however, is
accompanied with the morbidity, higher blood loss, and
longer convalescence period associated with laparotomy.
Since the original report by McCullough and coworkers
in 1991,
1
5 there have been several case reports which
describe laparoscopically directed internal drainage and
marsupialization of lymphocysts.
5-1
0 Retrospective analy-
ses have demonstrated an apparent decrease in blood
loss, length of hospital stay, and time of convalescence
among patients treated with a laparoscopic approach
compared to those treated by conventional laparotomy.
1
6
However, a significant difference in recurrence rates fol-
lowing surgical decompression between the two groups
was not demonstrable.
While laparoscopically directed drainage of pelvic lym-
phocysts following radical prostatectomy has been
described in a series of six isolated case reports (Table
2), marsupialization of a lymphocyst is described in only
one patient, and the use of an omental patch is described
in one patient.
8,
9 The technique described in the current
study has yet to be reported.
Moreover, the population described in this study com-
prises, to our knowledge, the largest series of patients
with pelvic lymphocysts resulting from the treatment of
gynecologic malignancy in which laparoscopically direct-
ed marsupialization has been reported.
In conclusion, the current study demonstrates that
laparoscopically directed marsupialization is technically
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Table 2.
Literature Review of Laparoscopic Internal Drainage of Lymphocysts Following Pelvic Lymphadenectomy
Author
Waples MJ
1992
7
Parra RO
1992
5
Bardot SF
1992
8
Iselin CE
19949
Gill IS
1995
6
Fallick ML
1996
1
0
Age
(yrs.)
69
67
69
72
57
41
(2 pts)
56
Lymphocysts
Size (cm)
15 cm
5 cm
10 cm
d
9.7 cm
Symptoms
Right leg edema,
No DVT
b
Right leg edema,
No DVT
Right leg edema,
No DVT,
failed external
drainage
Right leg edema,
No DVT,
failed external
drainage x3
c
Left
abdominal
pain
None
Operating
Time (min)
90 mins.
45 mins.
194 mins.
90 mins.
EBLa
(cc)
Minimal
—
34 cc
30 cc
Hospital
Stay (hrs.)
12 hours
<24 hours
36 hours
36 hours
48 hours
48 hours
<24 hours
Follow-Up
(months)
3 weeks
1 month
1 month
6 months
12.8 months
2 months
a Estimated blood loss
k Deep venous thrombophlebitis
c Omentum placed at the edge of the lymphocyst
d Cyst wall and peritoneal edges clipped together for marsupialization
feasible and effective in the management of pelvic lym-
phocysts. Further study of this technique appears to be
warranted.
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